Effective Vaccines for Global Health Challenges
Accelerate clinical trials and support research into novel vaccine technologies that can be distributed in low-resource settings, especially those that do not require cold chain.
Resources (5)
Footnotes to 10 technologies by Jacob Trefethen
Whitepapers and Essays
Slow Boring: The case for clinical trial abundance
Whitepapers and Essays
Strep A bacteria kill half a million a year. Why don’t we have a vaccine?
Whitepapers and Essays
CEPI
Research Org
R&D Gaps (1)
Many of the world’s most deadly diseases—such as tuberculosis, Group A Streptococcus, hepatitis C, hepatitis B, and syphilis—lack effective vaccines or cures. Additionally, the pace of developing effective, low-cost, therapeutics for emerging pathogens in low resource settings is too slow to meet gl...